- Home
- SER vs BAFN Comparison
SER vs BAFN Comparison
Compare SER & BAFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SER
- BAFN
- Stock Information
- Founded
- SER 2017
- BAFN 1999
- Country
- SER United States
- BAFN United States
- Employees
- SER N/A
- BAFN N/A
- Industry
- SER Biotechnology: Pharmaceutical Preparations
- BAFN Savings Institutions
- Sector
- SER Health Care
- BAFN Finance
- Exchange
- SER Nasdaq
- BAFN Nasdaq
- Market Cap
- SER 56.5M
- BAFN 65.2M
- IPO Year
- SER 2018
- BAFN N/A
- Fundamental
- Price
- SER $5.80
- BAFN $14.45
- Analyst Decision
- SER Strong Buy
- BAFN
- Analyst Count
- SER 1
- BAFN 0
- Target Price
- SER $11.00
- BAFN N/A
- AVG Volume (30 Days)
- SER 16.6K
- BAFN 13.0K
- Earning Date
- SER 08-08-2025
- BAFN 07-29-2025
- Dividend Yield
- SER N/A
- BAFN 2.17%
- EPS Growth
- SER N/A
- BAFN 116.26
- EPS
- SER N/A
- BAFN 2.37
- Revenue
- SER $51,000.00
- BAFN $80,167,000.00
- Revenue This Year
- SER N/A
- BAFN N/A
- Revenue Next Year
- SER N/A
- BAFN N/A
- P/E Ratio
- SER N/A
- BAFN $5.90
- Revenue Growth
- SER N/A
- BAFN 2.60
- 52 Week Low
- SER $3.81
- BAFN $11.50
- 52 Week High
- SER $11.57
- BAFN $19.75
- Technical
- Relative Strength Index (RSI)
- SER 57.53
- BAFN 46.70
- Support Level
- SER $5.50
- BAFN $13.85
- Resistance Level
- SER $6.29
- BAFN $14.95
- Average True Range (ATR)
- SER 0.52
- BAFN 0.86
- MACD
- SER 0.03
- BAFN -0.03
- Stochastic Oscillator
- SER 74.44
- BAFN 62.87
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.
About BAFN BayFirst Financial Corp.
BayFirst Financial Corp is a bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios. The company has various segment such as Real Estate(Residential, Commercial, and Construction & Land), Commercial and Industrial, Consumer.